• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Arco-Teva
    / Abic


    Active Ingredient
    Etoricoxib 60, 90 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    14 X 60 mg

    not in the basket chart 20086

    Tablets

    14 X 90 mg

    not in the basket chart 20087

    Dosage

    Osteoarthritis: The recommended dosage is 60 mg once a day, if necessary.
    Rheumatoid arthritis: The recommended dosage is 60 mg once a day, can be increased to a maximum of 90 mg once a day, if necessary.
    Ankylosing spondylitis: The recommended dosage is 60 mg once a day, can be increased to a maximum of 90 mg once a day, if necessary.
    Acute pain conditions: Etoricoxib should be used only for the acute painful period.
    Postoperative dental surgery pain: The recommended dosage is 90 mg once daily, limited to a maximum of 3 treatment days.


    Indications

    60 mg tablets: indicated for the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis.
    90 mg tablets: indicated for the symptomatic relief of rheumatoid arthritis (RA) and ankylosing spondylitis. For the short-term treatment of moderate pain associated with dental surgery.


    Contra-Indications

    Hypersensitivity to active substance or any of its excipients.
    Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and COX-2 inhibitors.
    Patients with peptic ulcer, bleeding or intestinal bleeding.
    Patients with severe hepatic disease.
    Patients with a severe renal  disease.
    Pregnancy. Lactation.
    Patients under 16 years of age.
    Patients with IBD , Crohn’s disease, ulcerative colitis.
    Patients with uncontrolled hypertension.
    Patients with heart failure (moderate or severe).
    Patients with ischemic heart disease or peripheral vascular disease (e.g. DVT).
    Patients with any kind of stroke, transient ischemic attack (TIA).
    Patients with history of miocardial infarction.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE